[Not Available].
作者信息
Sakulchit Teeranai, Benseler Susanne M, Goldman Ran D
出版信息
Can Fam Physician. 2017 Aug;63(8):e359-e362.
Abstract
摘要
相似文献
1
[Not Available].
Can Fam Physician. 2017 Aug;63(8):e359-e362.
本文引用的文献
1
The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers.
Korean J Pediatr. 2017 Jan;60(1):24-29. doi: 10.3345/kjp.2017.60.1.24. Epub 2017 Jan 24.
2
High-dose aspirin for Kawasaki disease: outdated myth or effective aid?
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):209-212. Epub 2017 Jan 5.
3
Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes.
J Pediatr. 2017 May;184:125-129.e1. doi: 10.1016/j.jpeds.2016.12.019. Epub 2016 Dec 30.
4
High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
PLoS One. 2015 Dec 10;10(12):e0144603. doi: 10.1371/journal.pone.0144603. eCollection 2015.
5
Effects of anti-inflammatory drugs on intravenous immunoglobulin therapy in the acute phase of Kawasaki disease.
Pediatr Cardiol. 2015 Feb;36(2):335-9. doi: 10.1007/s00246-014-1010-7. Epub 2014 Aug 27.
6
Update on etio and immunopathogenesis of Kawasaki disease.
Curr Opin Rheumatol. 2014 Jan;26(1):31-6. doi: 10.1097/BOR.0000000000000010.
7
Coronary artery outcomes among children with Kawasaki disease in the United States and Japan.
Int J Cardiol. 2013 Oct 9;168(4):3825-8. doi: 10.1016/j.ijcard.2013.06.027. Epub 2013 Jul 11.
8
Is high-dose aspirin necessary in the acute phase of kawasaki disease?
Korean Circ J. 2013 Mar;43(3):182-6. doi: 10.4070/kcj.2013.43.3.182. Epub 2013 Mar 31.
9
Epidemiology of Kawasaki disease: prevalence from national database and future trends projection by system dynamics modeling.
J Pediatr. 2013 Jul;163(1):126-31.e1. doi: 10.1016/j.jpeds.2012.12.011. Epub 2013 Jan 11.
10
Kawasaki disease.
Pediatr Clin North Am. 2012 Apr;59(2):425-45. doi: 10.1016/j.pcl.2012.03.009.
Zotero 插件